1Lounes KC, Lefkowitz JB, Coates AL, et al. Fibrinogen Longmout A heterozygous abnormal fibrinogen with B beta Arg-166 to Cys substitution associated with defective fibrin polymerization [ J ]. Ann N Y Acad Sci ,2001,936:129 - 132.
2Garza L,Ande YW,Saucedo JF. Can we prevent in-stent restenosis?[ J ]. Curr Opin Cardiol,2002,17 (5) :518 - 525.
3Acevedo M, Pearce GL, Kottke LD, et al. Elevated fibrinogen and homocysteine levels enhance the risk of mortality in patients from a high-risk preventive cardiology clinic [ J ]. Arterioscler Thromb Vasc Bid,2002,22(6): 1042 - 1045.
5Wang DS. Defibrinogenating effect of batroxin in vats and inhibition of migration of human vacular smooth muscle cells by the plasma of babroxobin-treated rats in vitro[ J]. Atherosclerosis ,2001 , 156 (1):73 - 80.
